KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that Laurence Reid, Ph.D., has been appointed to the Company's Board of Directors, effective imm
WALTHAM, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious...
First quarter 2024 revenues decreased 1% to $3.15 billion versus first quarter 2023; excluding RonapreveTM(a)(b), revenues increased 7%First quarter 2024...
Regeneron Pharmaceuticals Inc (REGN) reported a 15% increase in revenues to $3.36 billion in Q3 2023 compared to Q3 2022.Global net sales of Dupixent and Libta
Regeneron acquires Decibel Therapeutics for $4/share and a CVR linked to their promising gene therapy for hearing loss, DB-OTO. Read why I rate DBTX stock a Hold.
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
BALA CYNWYD, Pa., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to...
BALA CYNWYD, Pa., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to...
Gainers Broadwind Inc (NASDAQ: BWEN) shares climbed 85.4% to $4.19 after the company announced the receipt of approximately $175 million in new tower orders from a leading global wind turbine manufacturer.
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending,...
Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty.
Biotech stocks and secondary and initial ...